TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL
Clinical trial NCT04453345 · UNKNOWN
Trial details
- NCT number
- NCT04453345
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-20
- Primary completion
- 2023-05-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.